AT219355T - Medical aerosol formulations - Google Patents

Medical aerosol formulations

Info

Publication number
AT219355T
AT219355T AT98900837T AT98900837T AT219355T AT 219355 T AT219355 T AT 219355T AT 98900837 T AT98900837 T AT 98900837T AT 98900837 T AT98900837 T AT 98900837T AT 219355 T AT219355 T AT 219355T
Authority
AT
Austria
Prior art keywords
aerosol formulations
medical aerosol
medical
formulations
Prior art date
Application number
AT98900837T
Other languages
German (de)
Inventor
Manfred Keller
Kurt Herzog
Original Assignee
Jago Res Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CH24897 priority Critical
Application filed by Jago Res Ag filed Critical Jago Res Ag
Priority to PCT/CH1998/000037 priority patent/WO1998034595A1/en
Publication of AT219355T publication Critical patent/AT219355T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/124Aerosols; Foams characterised by the propellant
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/957Vapor emmitting composition
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/958Drug, bio-affecting and body treating compositions for smoking or inhaling
AT98900837T 1997-02-05 1998-02-02 Medical aerosol formulations AT219355T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CH24897 1997-02-05
PCT/CH1998/000037 WO1998034595A1 (en) 1997-02-05 1998-02-02 Medical aerosol formulations

Publications (1)

Publication Number Publication Date
AT219355T true AT219355T (en) 2002-07-15

Family

ID=4182679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98900837T AT219355T (en) 1997-02-05 1998-02-02 Medical aerosol formulations

Country Status (14)

Country Link
US (1) US6461591B1 (en)
EP (1) EP1014943B1 (en)
JP (1) JP2001511160A (en)
AT (1) AT219355T (en)
AU (1) AU718967B2 (en)
CA (1) CA2280099C (en)
DE (1) DE59804534D1 (en)
DK (1) DK1014943T3 (en)
ES (1) ES2178817T3 (en)
NO (1) NO993773L (en)
NZ (1) NZ337065A (en)
PT (1) PT1014943E (en)
WO (1) WO1998034595A1 (en)
ZA (1) ZA9800937B (en)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (en) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg New propellant gases and their use in drug preparations
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6218353B1 (en) * 1997-08-27 2001-04-17 Micell Technologies, Inc. Solid particulate propellant systems and aerosol containers employing the same
US6200352B1 (en) 1997-08-27 2001-03-13 Micell Technologies, Inc. Dry cleaning methods and compositions
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
AU748867B2 (en) * 1998-07-24 2002-06-13 Jagotec Ag Medicinal aerosol formulations
PL200941B1 (en) * 1998-11-13 2009-02-27 Jagotec Ag Dry powder for inhalation
IT1303788B1 (en) * 1998-11-25 2001-02-23 Chiesi Farma Spa Aerosol formulations of medicines.
DZ2947A1 (en) 1998-11-25 2004-03-15 Chiesi Farma Spa pressurized meter dose inhaler.
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
US20040002548A1 (en) * 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
US20100197719A1 (en) * 1999-05-12 2010-08-05 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
GB9908921D0 (en) * 1999-04-19 1999-06-16 Britannia Pharmaceuticals Ltd Spray dispenser for opiod antagonists
US6428769B1 (en) * 1999-05-04 2002-08-06 Aradigm Corporation Acute testosterone administration
US7258850B2 (en) 1999-05-04 2007-08-21 Aradigm Corporation Methods and compositions for treating erectile dysfunction
EP1175204A4 (en) * 1999-05-04 2006-05-31 Aradigm Corp Aerosol formulations and devices for increasing libido in women via acute testosterone administration
IT1313553B1 (en) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulations optimized consist of dasomministrare steroids solutions for inhalation.
WO2001019342A2 (en) * 1999-09-11 2001-03-22 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
DE19947235A1 (en) * 1999-09-30 2001-04-05 Asta Medica Ag New combination of loteprednol and beta¶2¶-adrenoceptor agonists
GB9928578D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Pharmaceutical formulations
US20030032632A1 (en) * 1999-12-24 2003-02-13 Crispps Leslie Alan Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317720B1 (en) * 2000-01-07 2003-07-15 Chiesi Farma Spa A device for the administration of pressurized metered dose aerosol inpropellenti hydrofluoroalkanes.
US6248136B1 (en) 2000-02-03 2001-06-19 Micell Technologies, Inc. Methods for carbon dioxide dry cleaning with integrated distribution
IT1317846B1 (en) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulations containing an anticholinergic drug for chronic obstructive pulmonary disease trattamentodella.
GB0008660D0 (en) 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
HU230804B1 (en) 2000-05-22 2018-06-28 Chiesi Farm Spa Stable pharmaceutical solution formulations for pressurised metered dose inhalers
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
GB0016876D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation
FR2812545B1 (en) * 2000-08-03 2003-03-28 Air Liquide Sante Int Aerosol inhalable medicated in the treatment or prevention of sweetness
GB0100560D0 (en) * 2001-01-09 2001-02-21 Lamination Technologies Ltd Clothing
HU229798B1 (en) * 2001-03-30 2014-07-28 Jagotec Ag Medical aerosol compositions and process for their preparation
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
EP1392262A1 (en) 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US6759029B2 (en) 2001-05-24 2004-07-06 Alexza Molecular Delivery Corporation Delivery of rizatriptan and zolmitriptan through an inhalation route
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
ES2222294T3 (en) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Optimized formulation for tobramycin aerosol administration.
US7078016B2 (en) 2001-11-21 2006-07-18 Alexza Pharmaceuticals, Inc. Delivery of caffeine through an inhalation route
BR0308274A (en) 2002-03-01 2004-12-28 Chiesi Farma Spa Superfine formoterol Formulation
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
EP3308772A1 (en) * 2002-06-28 2018-04-18 Civitas Therapeutics, Inc. Inhalable epinephrine
JP2005539042A (en) * 2002-08-09 2005-12-22 ヴィアトリス ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディートゲゼルシャフトVIATRIS GmbH & Co.KG Novel combination of a glucocorticoid and pde-4-inhibitors to treat respiratory diseases, allergic diseases, asthma and copd
DK1567164T3 (en) 2002-11-26 2009-05-18 Alexza Pharmaceuticals Inc Use of Loxapine for the manufacture of a medicament for the treatment of pain
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
CA2507158A1 (en) * 2002-11-26 2004-06-10 Alexza Molecular Delivery Corporation Treatment of headache with antipsychotics delivered by inhalation
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
CN1726045A (en) * 2002-12-13 2006-01-25 大塚制药株式会社 Freeze-dried interferon-gamma composition for transpulmonary administration and inhalation system therefor
GB0229714D0 (en) * 2002-12-20 2003-01-29 Glaxo Group Ltd Novel apparatus and method
DE10260882B4 (en) * 2002-12-24 2007-02-08 IG Sprühtechnik GmbH & Co. KG MDIs containing soy lecithin as a surfactant and its use
WO2004075874A1 (en) * 2003-02-28 2004-09-10 Anbics Patents-Licences Ag Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolides
EP1625333A1 (en) 2003-05-21 2006-02-15 Alexza Pharmaceuticals, Inc. Self-contained heating unit and drug-supply unit employing same
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050043343A1 (en) * 2003-07-28 2005-02-24 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
WO2005032521A2 (en) * 2003-10-02 2005-04-14 Collegium Pharmaceutical, Inc. Non-flammable topical anesthetic liquid aerosols
US20060188449A1 (en) * 2003-10-03 2006-08-24 Jane Hirsh Topical aerosol foams
GB0323684D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0323685D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
US20050238632A1 (en) * 2004-04-23 2005-10-27 Alburty David S Propellant formulations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
WO2005115336A2 (en) * 2004-05-15 2005-12-08 Collegium Pharmaceutical, Inc. Sprayable formulations for the treatment of acute inflammatory skin conditions
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US8846079B1 (en) * 2004-12-01 2014-09-30 Vgsk Technologies, Inc. Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
US20060115523A1 (en) * 2004-12-01 2006-06-01 Konduri Kameswari S Sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal
WO2006076222A2 (en) * 2005-01-10 2006-07-20 Glaxo Group Limited Pharmaceutical formulations
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
JP2009526003A (en) * 2006-02-10 2009-07-16 パーリ・ファルマ・ゲーエムベーハー Spray-like antibiotic for inhalation therapy
US20080269347A1 (en) * 2006-09-28 2008-10-30 Azopharma, Inc. Epinephrine formulations
EP2152274A4 (en) * 2007-05-07 2010-07-21 Questor Pharmaceuticals Inc Nasal administration of benzodiazepines
US8652443B2 (en) * 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
WO2010147631A1 (en) * 2009-06-16 2010-12-23 Wen Tan Use of r-bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
US9241904B1 (en) 2011-08-19 2016-01-26 Intech Biopharm Ltd. Method for preparing metered dose sprayed inhaler for treating respiratory disease
TWI399202B (en) * 2011-03-17 2013-06-21 Intech Biopharm Ltd The preparation for formulation composition and manufacturing processes of metered dose inhalers treated respiratory diseases
GB201108039D0 (en) * 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
WO2012174158A2 (en) 2011-06-14 2012-12-20 Hale Biopharma Ventures, Llc Administration of benzodiazepine
US10034857B2 (en) 2015-07-02 2018-07-31 Civitas Therapeutics, Inc. Triptan powders for pulmonary delivery

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (en) 1956-03-21 1900-01-01
BE556587A (en) 1957-01-31 1957-04-11
US4139617A (en) 1974-05-13 1979-02-13 Richardson-Merrell Inc. 19-Oxygenated-androst-5-enes for the enhancement of libido
CA1075854A (en) * 1976-08-16 1980-04-22 Charles W. Simons Aerosol propellants for personal products
NL7708731A (en) 1976-08-13 1978-02-15 Montedison Spa A process for the preparation of new propellant compositions for aerosols.
JPS61158919A (en) 1984-12-28 1986-07-18 Taisho Pharmaceut Co Ltd Remedy for athlete's foot
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
DE4003272A1 (en) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg New propellant mixtures and their use in drug preparations
ES2096653T3 (en) 1990-06-29 1997-03-16 Fisons Plc Pressurized aerosol compositions.
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ES1018186Y (en) 1991-05-17 1992-08-16 Cano Rodriguez Andres Support for a therapeutic magnet.
DK0550031T3 (en) 1991-12-31 1996-08-26 Solvay medical aerosol formulation
SE523661C2 (en) * 1992-02-05 2004-05-04 American Pacific Corp The gas-liquid mixture intended for use as fire extinguishing agents
AU1449092A (en) 1992-02-24 1993-09-13 Triton Diagnostics, Inc. Bridge immunoassay
US5301664A (en) * 1992-03-06 1994-04-12 Sievers Robert E Methods and apparatus for drug delivery using supercritical solutions
GB9214765D0 (en) * 1992-07-11 1992-08-26 Smithkline Beecham Plc Pressurised aerosol formulation
WO1994003056A1 (en) * 1992-07-31 1994-02-17 Ian Alexander Edwin Maccormick Aerosol insecticide composition
MY131733A (en) * 1994-12-22 2007-08-30 Astra Ab Aerosol drug formulations

Also Published As

Publication number Publication date
DK1014943T3 (en) 2002-10-14
DE59804534D1 (en) 2002-07-25
ES2178817T3 (en) 2003-01-01
WO1998034595A1 (en) 1998-08-13
US6461591B1 (en) 2002-10-08
PT1014943E (en) 2002-11-29
NZ337065A (en) 2001-02-23
JP2001511160A (en) 2001-08-07
ZA9800937B (en) 1998-08-06
EP1014943A1 (en) 2000-07-05
NO993773L (en) 1999-10-04
CA2280099A1 (en) 1998-08-13
AU5649698A (en) 1998-08-26
CA2280099C (en) 2005-12-27
NO993773D0 (en) 1999-08-04
EP1014943B1 (en) 2002-06-19
AU718967B2 (en) 2000-05-04

Similar Documents

Publication Publication Date Title
DE69835444D1 (en) The surgical instrument
DE69837488D1 (en) Steerable surgical instrument
DE69816852D1 (en) cyclone
DE69804995T2 (en) cyclone
DE69830650D1 (en) surgical spreader
DE69838720D1 (en) Lipoprotein-regulating drug
DE69822059D1 (en) disposable diaper
DE69828931D1 (en) disposable diaper
DE69618624D1 (en) inhaler
AT525982T (en) Human intervertebral-prosthesis
NO20003303L (en) Vaccine
NO20000850D0 (en) Vaccine
DE69730488D1 (en) Bipolar acetabulum
NO20002896D0 (en) HÕrfarvemiddel preparation
DE69816460D1 (en) Schweinecircoviren derived vaccines
DE69419519D1 (en) formulations fragrances
DE19581805T1 (en) pharmaceutical compositions
DE69709547T2 (en) Disposable pull-underpants
DE69723202D1 (en) inhalers
AT223646T (en) Agrochemical formulations
DE69815565D1 (en) pesticidal compositions
DE69838800D1 (en) Distal protection device
TR199901077A3 (en) Pharmaceutical formulations.
DE69533404D1 (en) Diferentiell biodegradable medical inplantate
TR199501673A1 (en) Aerosol drug formulations.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner